ArticleClinical cancer research : an official journal of the American Association for Cancer Research2012

CCT244747 is a novel potent and selective CHK1 inhibitor with oral efficacy alone and in combination with genotoxic anticancer drugs.

Mike I Walton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.